Status:
COMPLETED
Pharmacokinetics of Different Mode Administration of Intranasal Dexmedetomidine
Lead Sponsor:
The University of Hong Kong
Conditions:
Bioavailability
Dexmedetomidine
Eligibility:
All Genders
18-50 years
Phase:
PHASE3
Brief Summary
Intranasal dexmedetomidine has been studied and used in children for premedication before anaesthesia or fro sedation. It can be administered by simple dripping or by Mucosal Atomization Device (MAD®)...
Detailed Description
This is a three-period crossover double-blinded study. 8 subjects will be recruited and they will attend 3 study sessions after informed written and verbal consent. They would have dexmedetomidine adm...
Eligibility Criteria
Inclusion
- healthy volunteer ASA 1 age over 18 no other concomitant drug therapy no alcohol or smoking habit -
Exclusion
- \-
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT03323593
Start Date
May 1 2013
End Date
December 1 2013
Last Update
October 27 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, Hong Kong